• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

Rapid pink-eye tests are now available in one state

Article

MinuteClinic now offers a rapid conjunctivitis test at its 23 locations inside select pharmacy stores in the Atlanta area, according to a prepared statement.

Atlanta

-MinuteClinic now offers a rapid conjunctivitis test at its 23 locations inside select pharmacy stores in the Atlanta area, according to a prepared statement.

The clinic’s nurse practitioners can use the test to diagnose accurately whether a patient has viral or bacterial conjunctivitis, and then practitioners can identify an appropriate course of treatment, eliminating unnecessary antibiotic prescriptions, the company said.

“MinuteClinic patients will get on-the-spot results that provide a more precise pink-eye diagnosis,” said Donna Haugland, MinuteClinic chief nursing officer. “This helps prevent the overuse of antibiotics and can lead to prescription savings.”

Although treatment for conjunctivitis with antibiotics is necessary in only 40% to 60% of cases, the majority of medical professionals prescribe antibiotics nearly 100% of the time, according to the release.

“Our goal was to develop new medical technology that improves patient outcomes and results in the highest level of care,” said Robert Sambursky, MD, chief medical officer for Rapid Pathogen Screening (RPS) Inc. “The [test] gives medical professionals a safe, convenient, and affordable option to diagnose pink eye.”

The test is a pilot project conducted in partnership with RPS, and MinuteClinic said that it hopes to offer the test nationally at a future date in its clinic locations in 25 states.

Related Videos
Video 3 - "Approaching Asymptomatic Cases with Risk Factors"
Video 2 - "Do Dry Eye Diagnostics Change the Management of Dry Eye?"
Elias Kahan, MD, speaks at the 2024 ARVO meeting
Andrew Pucker, OD, PhD
Dr. SriniVas Sadda Discusses Vision for ARVO as New President: Collaboration, Funding Challenges, and Impact of Annual Meetings
© 2024 MJH Life Sciences

All rights reserved.